VIBROSTREP

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

streptomycin sulphate; dihydrostreptomycin sulphate

Available from:

Virbac New Zealand Limited

INN (International Name):

dihydrostreptomycin sulphate, streptomycin sulphate

Composition:

streptomycin sulphate 250 g/litre; dihydrostreptomycin sulphate 250 g/litre

Therapeutic area:

Antibiotic

Authorization status:

ACVM Registered

Authorization date:

1976-06-16

Summary of Product characteristics

VIBROSTREP - August 2019
Draft label (for vial/pack and outer container)
Left panel
For the treatment of Bovine Vibriosis:
Cows: Infuse 2-10mL into the uterus and inject 3-4mL per 100kg b.w. by
subcutaneous or intramuscular injection daily for 3 days.
Bulls: Infuse and massage 2-10mL into the preputial cavity and inject
3-4mL per
100kg b.w. by subcutaneous or intramuscular injection daily for 3
days.
For the treatment of Vibrioisis (Campylobacteriosis), Leptospirosis,
Actinobacillosis (Woody Tongue) and other infections caused by
organisms
susceptible to Streptomycin and Dihydrostreptomycin, in PIGS, SHEEP
and
CATTLE, inject 3-4 mL per 100kg b.w. by subcutaneous or intramuscular
injection daily for 3 days. In food producing animals, injection must
be in the
anterior half of the neck.
Registered pursuant to the ACVM Act 1997, No. A3144.
See www.foodsafety.govt.nz for registration conditions.
Centre panel
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
VIBROSTREP
Each mL contains Streptomycin (as sulphate) 250mg
and Dihydrostreptomycin (as sulphate) 250mg
500
Registered to and manufactured in New Zealand by
NZ Made Logo
VIRBAC NEW ZEALAND LIMITED
100mL
30 Maui St, Pukete Park, P.O. Box 10305
1225-5-02/03
Hamilton
Right panel
STERILE INJECTION. KEEP OUT OF REACH OF CHILDREN. PROTECT
FROM DIRECT SUNLIGHT. STORE IN A COOL PLACE.
Contraindications: Not for use in Bobby calves. Not to be used in the
treatment
of infections caused by organisms known to be resistant to
streptomycin or
dihydrostreptomycin. Not recommended for use in animals with renal
dysfunction
or which are already being treated with aminoglycoside (-mycins)
antibiotics.
WITHHOLDING PERIODS
It is an offence for users of this product to cause residues exceeding
the
relevant MRL in the Food Notice: Maximum Residue Levels for
Agricultural
Compounds.
Meat: Animals producing meat or offal for human consumption must not
be sold
for slaughter either during treatment or within 30 days of cessation
of the last
treatment.
Milk: Milk intended for sale for